Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-01-19
1977-01-11
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 3154
Patent
active
040027481
ABSTRACT:
Sterile, essentially amorphous cefazolin sodium for parenteral administration, having an improved solubility on reconstitution, is prepared by a freeze-drying process wherein a sterile solution of from about 10 to about 25 percent (W/V) of cefazolin sodium is exposed to an environment wherein the temperature is held at from about minus 50.degree. C. to minus 55.degree. C. until the temperature of the solution (frozen) is reduced to minus 48.degree. C. to minus 55.degree. C. before subjecting said frozen solution to a high vacuum and a moderate amount of heat to sublime the water therefrom.
REFERENCES:
patent: 3303193 (1967-02-01), Godfrey
patent: 3335136 (1967-08-01), Flynn
The Merck Index, 8th Edition, p. 222, (1968).
Bornstein Michael
Carone Sandra M.
Eli Lilly and Company
Ernsberger Ralph W.
Meyers Albert T.
Smith Everet F.
Stephens Daren M.
LandOfFree
Method of preparing sterile essentially amorphous cefazolin for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing sterile essentially amorphous cefazolin for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing sterile essentially amorphous cefazolin for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1743905